Stem cell therapy for Alport syndrome: The hope beyond the hype

Nephrology Dialysis Transplantation

Volumn 24, Issue 3, 2009, Pages 731-734

  Gross, Oliver ^a,s   Borza, Dorin Bogdan ^b   Anders, Hans Joachim ^c   Licht, Christoph ^d   Weber, Manfred ^e   Segerer, Stephan ^f   Torra, Roser ^g   Gubler, Marie Claire ^h   Heidet, Laurence ⁱ   Harvey, Scott ^h   Cosgrove, Dominic ^j   Lees, George ^k   Kashtan, Clifford ^l   Gregory, Martin ^m   Savige, Judy ⁿ   Ding, Jie ^o   Thorner, Paul ^d   Abrahamson, Dale R ^p   Antignac, Corinne ^h   Tryggvason, Karl ^q   Hudson, Billy ^b   Miner, Jeffrey H ^r   more..

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

^f UNIVERSITY OF ZURICH   (Switzerland)

^g FUNDACIÓ PUIGVERT   (Spain)

^h INSERM   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^k TEXAS A AND M UNIVERSITY   (United States)

^l UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

^o PEKING UNIVERSITY   (China)

^p UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^q KAROLINSKA INSTITUTE   (Sweden)

^r WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

more..

Author keywords

Alport syndrome; Bone marrow transplantation; Renal fibrosis; Stem cell therapy

Indexed keywords

TUMSTATIN;

ALPORT SYNDROME; ARTICLE; BONE MARROW TRANSPLANTATION; DISEASE COURSE; FIBROSING ALVEOLITIS; GLOMERULUS BASEMENT MEMBRANE; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY FUNCTION; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; WILD TYPE;

ANIMALS; AUTOANTIGENS; COLLAGEN TYPE IV; HUMANS; KIDNEY FAILURE; MICE; NEPHRITIS, HEREDITARY; STEM CELL TRANSPLANTATION;

EID: 60749123076     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn722     Document Type: Article

References (13)

1. Hudson B, Tryggvason K, Sundaramoorthy M et al. Alport's syndrome, goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348: 25
2. Katayama K, Kawano M, Naito I et al. Irradiation prolongs survival of Alport mice. J Am Soc Nephrol 2008; 19: 1692-1700
3. Prodromidi EI, Poulsom R, Jeffery R et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 2006; 24: 2448-2455
4. Sugimoto H, Mundel TM, Sund M et al. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci USA 2006; 103: 7321-7326
5. Ninichuk V, Gross O, Segerer S et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen 4A3-deficient mice. Kidney Int 2006; 70: 121-129
6. Andrews KL, Mudd JL, Li C et al. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. Am J Pathol 2002; 160: 721-730
7. Kang JS, Wang XP, Miner JH et al. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha 5 alpha 6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice. J Am Soc Nephrol 2006; 17: 1962-1969
8. LeBleu VS, Kalluri R. Stem cell-based therapy for glomerular diseases: an evolving concept. J Am Soc Nephrol 2008; 19: 1621-1623
9. Heidet L, Cai Y, Guicharnaud L et al. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys. Am J Pathol 2000; 156: 1901-1910
10. Harvey SJ, Zheng K, Sado Y et al. Role of distinct type IV collagen networks in glomerular development and function. Kidney Int 1998; 54: 1857-1866
11. Rheault MN, Kren SM, Thielen BK et al. Mouse model of X-linked Alport syndrome. J Am Soc Nephrol 2004; 15: 1466-1474
12. Cosgrove D, Rodgers K, Meehan D et al. Integrin alpha 1 beta 1 and transforming growth factor-beta1 play distinct roles in Alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol 2000; 157: 1649-1659
13. Hamano Y, Grunkemeyer JA, Sudhakar A et al. Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 2002; 277: 31154-31162